These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9930317)

  • 41. Evidence for regulation of oxidative stress by latent membrane protein 1 oncoprotein in patients with low-grade leukemic B cell lymphoma with latent Epstein-Barr virus infection.
    Papadopoulou V; Diamantopoulos PT; Kontandreopoulou E; Polonyfi K; Variami E; Kouzis P; Galanopoulos A; Spanakis N; Zervakis K; Iliakis T; Perrea D; Kollia P; Vassilakopoulos TP; Pangalis GA; Kyrtsonis C; Vaiopoulos G; Viniou NA
    Leuk Lymphoma; 2014 Aug; 55(8):1904-9. PubMed ID: 24261679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.
    Miller CL; Longnecker R; Kieff E
    J Virol; 1993 Jun; 67(6):3087-94. PubMed ID: 7684459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin E inhibits cyclosporin A and H2O2 promoted Epstein-Barr virus (EBV) transformation of human B cells as assayed by EBV oncogene LMP1 expression.
    Chen C; Reddy KS; Johnston TD; Khan TT; Ranjan D
    J Surg Res; 2003 Aug; 113(2):228-33. PubMed ID: 12957134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders.
    Ouyang J; Juszczynski P; Rodig SJ; Green MR; O'Donnell E; Currie T; Armant M; Takeyama K; Monti S; Rabinovich GA; Ritz J; Kutok JL; Shipp MA
    Blood; 2011 Apr; 117(16):4315-22. PubMed ID: 21300977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase.
    Longnecker R; Druker B; Roberts TM; Kieff E
    J Virol; 1991 Jul; 65(7):3681-92. PubMed ID: 1710288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation.
    Tsai SC; Lin SJ; Lin CJ; Chou YC; Lin JH; Yeh TH; Chen MR; Huang LM; Lu MY; Huang YC; Chen HY; Tsai CH
    J Virol; 2013 Aug; 87(16):9041-52. PubMed ID: 23760235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder.
    Hatton O; Martinez OM; Esquivel CO
    Pediatr Transplant; 2012 May; 16(3):220-9. PubMed ID: 22353174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stimulation of Epstein-Barr virus-infected human B cell growth by physiological concentrations of 4-hydroxynonenal.
    Ranjan D; Chen C; Johnston TD; Jeon H; Ibrahim M; Drake J; Butterfield DA
    Cell Biochem Funct; 2006; 24(2):147-52. PubMed ID: 15651079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of bcl-2 and Epstein-Barr virus LMP1 in lymphocytic interstitial pneumonia.
    Kaan PM; Hegele RG; Hayashi S; Hogg JC
    Thorax; 1997 Jan; 52(1):12-6. PubMed ID: 9039233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PKD1 is critical for Epstein-Barr virus LMP1-induced protection of malignant B cells from cell death induced by rituximab.
    Kim JH; Kim WS; Park C
    Leuk Lymphoma; 2015 Jan; 56(1):194-201. PubMed ID: 24707946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-kappaB transactivation.
    Gennari F; Mehta S; Wang Y; St Clair Tallarico A; Palu G; Marasco WA
    J Mol Biol; 2004 Jan; 335(1):193-207. PubMed ID: 14659750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of Immunogenicity of Intracellular CTAR Fragments of Epstein-Barr Virus Latent Phase Protein LMP1.
    Lomakin YA; Shmidt AA; Bobik TV; Chernov AS; Pyrkov AY; Aleksandrova NM; Okunola DO; Vaskina MI; Ponomarenko NA; Telegin GB; Dubina MV; Belogurov AA
    Bull Exp Biol Med; 2017 Oct; 163(6):766-771. PubMed ID: 29063322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B1.12: a novel peptide interacting with the extracellular loop of the EBV oncoprotein LMP1.
    Ammous-Boukhris N; Mosbah A; Ayadi W; Sahli E; Chevance S; Bondon A; Gargouri A; Baudy-Floc'h M; Mokdad-Gargouri R
    Sci Rep; 2019 Mar; 9(1):4389. PubMed ID: 30867462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of EBV latent membrane protein 1 expression in lymphomas: evidence from 15 studies.
    Mao Y; Lu MP; Lin H; Zhang DW; Liu Y; Li QD; Lv ZG; Xu JR; Chen RJ; Zhu J
    PLoS One; 2013; 8(4):e60313. PubMed ID: 23613723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of therapeutic antibodies by vaccination against external loops of tumor-associated viral latent membrane protein.
    Delbende C; Verwaerde C; Mougel A; Tranchand Bunel D
    J Virol; 2009 Nov; 83(22):11734-45. PubMed ID: 19726497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of the free sphingosine levels in Epstein Barr virus transformed human B lymphocytes by phorbol dibutyrate.
    Miccheli A; Ricciolini R; Lagana A; Piccolella E; Conti F
    Biochim Biophys Acta; 1991 Oct; 1095(1):90-2. PubMed ID: 1657192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.
    Zhang C; Ötjengerdes RM; Roewe J; Mejias R; Marschall ALJ
    BioDrugs; 2020 Aug; 34(4):435-462. PubMed ID: 32301049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of human Fab antibody fragments specific to LMP1 (HLEAFab) in nasopharyngeal carcinoma for potential molecular diagnosis and therapeutic applications.
    Zhang D; Mao Y; Xiong L; Cao Q; Zhu J; Chen R
    Oncol Lett; 2013 May; 5(5):1694-1698. PubMed ID: 23760364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation and characterization of a novel recombinant antibody against LMP1-TES1 of Epstein-Barr virus isolated by phage display.
    Zhang D; Mao Y; Cao Q; Xiong L; Wen J; Chen R; Zhu J
    Viruses; 2013 Apr; 5(4):1131-42. PubMed ID: 23609879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of drugs for Epstein-Barr virus using high-throughput in silico virtual screening.
    Li N; Thompson S; Jiang H; Lieberman PM; Luo C
    Expert Opin Drug Discov; 2010 Dec; 5(12):1189-203. PubMed ID: 22822721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.